申请人:Ebewe Arzneimittel Gesellschaft m.b.H.
公开号:US05100911A1
公开(公告)日:1992-03-31
Thienyloxyalkylamine derivatives of the general formula: ##STR1## wherein --O--CH.sub.2 --CH.sub.2 --NR.sub.2 R.sub.3 is in position 4 or 5 of the thiophene ring; R.sub.1 is hydrogen, halogen, CF.sub.3, alkyl or alkoxy; R.sub.2 and R.sub.3 are the same or different and are each alkyl, cycloalkyl, alkenyl or alkynyl each having up to 8 C atoms, or NR.sub.2 R.sub.3 is a 5 to 7-membered saturated heterocyclic ring optionally containing a further hetero atom which is oxygen or nitrogen optionally substituted by an alkyl group having 1 to 3 C atoms; and n is an integer of 1 to 5; as well as their acid addition salts, are suitable for treatment of heart rhythm disturbances.
通式为:##STR1##的Thienyloxyalkylamine衍生物,其中--O--CH.sub.2 --CH.sub.2 --NR.sub.2 R.sub.3位于噻吩环的4或5位; R.sub.1为氢、卤素、CF.sub.3、烷基或烷氧基; R.sub.2和R.sub.3相同或不同,分别为烷基、环烷基、烯基或炔基,每个原子有多达8个碳,或NR.sub.2 R.sub.3是一个5到7个成员的饱和杂环环,可选地含有进一步的杂原子,其为氧或氮,可选地由具有1到3个碳原子的烷基基团取代; n是1到5的整数;以及它们的酸加成盐,适用于治疗心律失常。